Raymond James Upgrades Guardant Health to Outperform, Announces $27 Price Target
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Andrew Cooper has upgraded Guardant Health (NASDAQ:GH) from Market Perform to Outperform and set a price target of $27.

November 13, 2023 | 12:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guardant Health was upgraded by Raymond James from Market Perform to Outperform with a new price target of $27.
Analyst upgrades typically lead to a positive short-term reaction in the stock market as they suggest a better outlook for the company's performance. The new price target of $27 indicates a potential upside from the current trading price, which may attract investors.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100